Decreases in Left Atrial Strain with Mavacamten Therapy and Associations with Atrial Fibrillation. (PubMed, Am J Cardiol) - Sep 30, 2026 - "Decreases in LAS seen with mavacamten may be downstream effects of alterations to other hemodynamic parameters, a decline in atrial function, or a combination thereof. LAS reductions may therefore represent harmful effects on the left atrium or neutral byproducts of other changes, although the association between LAS and AF is notable and may highlight prognostic implications of strain measurements in this population."
Journal • Atrial Fibrillation • Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy • Obstructive Hypertrophic Cardiomyopathy
|
|
Allison Perry; Anna Parrish; Christopher M Kramer; James P MacNamara; Jonathan R Lindner; Kaitlyn Amos; Karen Mcclean; Kenneth C Bilchick; Matthew Thomas; Michael Ayers; Myra Lewontin; Yaqub Betz
|